182 related articles for article (PubMed ID: 10540171)
1. Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.
Hildner K; Finotto S; Becker C; Schlaak J; Schirmacher P; Galle PR; Märker-Hermann E; Neurath MF
Clin Exp Immunol; 1999 Oct; 118(1):137-46. PubMed ID: 10540171
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate analogues display enhanced inhibition of TNF-α production in whole blood from RA patients.
van der Heijden JW; Assaraf YG; Gerards AH; Oerlemans R; Lems WF; Scheper RJ; Dijkmans BA; Jansen G
Scand J Rheumatol; 2014; 43(1):9-16. PubMed ID: 23987246
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
[TBL] [Abstract][Full Text] [Related]
4. The effect of methotrexate (MTX) on expression of signalling lymphocytic activation molecule (SLAM) in patients with rheumatoid arthritis (RA) and its role in the regulation of cytokine production.
Morita Y; Fukazawa T; Hirashima M; Kaga K; Kusaoi M; Morita T; Touyama S; Morita K; Takasaki Y; Hashimoto H
Scand J Rheumatol; 2006; 35(4):268-72. PubMed ID: 16882589
[TBL] [Abstract][Full Text] [Related]
5. Effect of Sanhuangyilong decoction plus methotrexate on tumor necrosis factor alpha and interferon gamma in serum and synovial fluid in rheumatoid arthritis patients with symptom pattern of damp heat obstruction.
Liu D; Yan J; Yun M; Yang M; Luo Y; Zhang J; Guo M; Yang M; Yuan W; Zou W; Li H; Hu Y
J Tradit Chin Med; 2016 Oct; 36(5):625-33. PubMed ID: 29933531
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.
Neurath MF; Hildner K; Becker C; Schlaak JF; Barbulescu K; Germann T; Schmitt E; Schirmacher P; Haralambous S; Pasparakis M; Meyer Zum Büschenfelde KH; Kollias G; Märker-Hermann E
Clin Exp Immunol; 1999 Jan; 115(1):42-55. PubMed ID: 9933419
[TBL] [Abstract][Full Text] [Related]
7. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
[TBL] [Abstract][Full Text] [Related]
8. A novel predictor of clinical response to methotrexate in patients with rheumatoid arthritis: a pilot study of in vitro T cell cytokine suppression.
Haroon N; Srivastava R; Misra R; Aggarwal A
J Rheumatol; 2008 Jun; 35(6):975-8. PubMed ID: 18464312
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.
van Roon JA; Glaudemans KA; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2003 Feb; 62(2):113-9. PubMed ID: 12525379
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis.
Walter GJ; Fleskens V; Frederiksen KS; Rajasekhar M; Menon B; Gerwien JG; Evans HG; Taams LS
Arthritis Rheumatol; 2016 Jan; 68(1):103-16. PubMed ID: 26314565
[TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin K
Xu W; Wu H; Tahara K; Chen S; Wang X; Tanaka S; Sugiyama K; Sawada T; Hirano T
Fundam Clin Pharmacol; 2021 Oct; 35(5):832-842. PubMed ID: 33780033
[TBL] [Abstract][Full Text] [Related]
12. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
Lina C; Conghua W; Nan L; Ping Z
J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
[TBL] [Abstract][Full Text] [Related]
14. Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127(low) regulatory T cells.
Walter GJ; Evans HG; Menon B; Gullick NJ; Kirkham BW; Cope AP; Geissmann F; Taams LS
Arthritis Rheum; 2013 Mar; 65(3):627-38. PubMed ID: 23280063
[TBL] [Abstract][Full Text] [Related]
15. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis.
Cribbs AP; Kennedy A; Penn H; Amjadi P; Green P; Read JE; Brennan F; Gregory B; Williams RO
Arthritis Rheumatol; 2015 May; 67(5):1182-92. PubMed ID: 25604080
[TBL] [Abstract][Full Text] [Related]
17. Regulation by corticosteroids of Th1 and Th2 cytokine production in human CD4+ effector T cells generated from CD45RO- and CD45RO+ subsets.
Brinkmann V; Kristofic C
J Immunol; 1995 Oct; 155(7):3322-8. PubMed ID: 7561025
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.
Gerards AH; de Lathouder S; de Groot ER; Dijkmans BA; Aarden LA
Rheumatology (Oxford); 2003 Oct; 42(10):1189-96. PubMed ID: 12777636
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of experimental rheumatoid arthritis with low-dose methotrexate by increasing partially CD4+CD25+ Treg cells and inducing Th1 to Th2 shift in both cells and cytokines.
Xinqiang S; Fei L; Nan L; Yuan L; Fang Y; Hong X; Lixin T; Juan L; Xiao Z; Yuying S; Yongzhi X
Biomed Pharmacother; 2010 Sep; 64(7):463-71. PubMed ID: 20359858
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
